WHAT THEY ARE SAYING: AMERICANS NATIONWIDE CALL ON CONGRESS TO LOWER RX PRICES NOW
Oct 21, 2021
Broad Array of Leaders Encourage Lawmakers to Capitalize on Unprecedented… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
SECOND OPINION: BIG PHARMA TROTS OUT BOGUS R&D DEFENSE TO OPPOSE TAX
Aug 9, 2021
Remembering Drug Companies Spend Their Profits on Shareholders and Marketing… Read More
BIG PHARMA EARNINGS WATCH: ASTRAZENECA, SANOFI, MERCK, ABBVIE, ELI LILLY & AMGEN
Aug 6, 2021
Q2 Earnings Reports Continue to Show Pandemic Price Hikes Profitable for Brand… Read More
BIG PHARMA EARNINGS WATCH: PFIZER, GLAXO SMITH KLINE, BRISTOL MYERS SQUIBB
Jul 30, 2021
Big Pharma Companies Continue to Rake in Massive Profits After Three Rounds of… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON, NOVARTIS, ROCHE
Jul 22, 2021
New Round of Earnings Reports Show Big Pharma Companies Riding High on Massive… Read More
SECOND OPINION: PHARMA-BACKED REBATE RULE WOULD HIKE SENIOR PREMIUMS, BOOST DRUG COMPANY PROFITS
Jul 22, 2021
Big Pharma Wants Implementation of Misguided Policy that Does Nothing to Lower… Read More
THEY SAID IT! U.S. SENATE JUDICIARY SUBCOMMITTEE HIGHLIGHTS BIG PHARMA’S ANTI-COMPETITIVE PRACTICES
Jul 14, 2021
Lawmakers Showcase How Big Pharma’s Patent Abuse Drives Out-of-Control… Read More
DOSE OF REALITY: LAWMAKERS TO PROBE BIG PHARMA PATENT ABUSE AS INNOVATION EXCUSES CRUMBLE
Jul 13, 2021
U.S. Senate Judiciary Subcommittee Hearing Tuesday Will Build on Momentum for… Read More
BIG PHARMA WATCH: JULY PRICE HIKES CLIMB TO 52
Jul 7, 2021
Brand Name Drug Companies Stick to Business-as-Usual in Third Major Round of… Read More
BIG PHARMA WATCH: HEADLINES SHOW BIOGEN ADHUHELM PRICING HAS REIGNITED URGENCY TO HOLD BIG PHARMA ACCOUNTABLE
Jun 25, 2021
Coverage Highlights Backlash Over Massive Price Tag for Unproven Treatment,… Read More
SECOND OPINION: PFIZER’S PHONY CALL FOR LOWER DRUG COSTS
Jun 22, 2021
CEO Sidesteps Big Pharma’s Pricing Practices; Pushes Proposals That Would… Read More
WHAT THEY ARE SAYING: BIOGEN’S “SIMPLY UNACCEPTABLE” ADUCANUMAB PRICING HIGHLIGHTS URGENCY FOR RX SOLUTIONS
Jun 14, 2021
Broad-based Opposition to Egregious Launch Price on Drug With Unproven… Read More